Walk-in || Instrument Engineer Executive

Concord Biotech Limited is a R&D driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. Concord, founded in the year 2000 has transformed from a single-product company to a broad-spectrum solution provider, offering products across diversified therapeutic segments.

Concord is globally known for its products and has a presence in more than 70 countries worldwide with efficient distribution infrastructure in markets like the USA, Europe, Japan, Latin America, Africa, Asia, besides significant presence in Indian market. Concord is actively expanding its horizons by partnering with leading global pharmaceutical companies by meeting their product development needs for APIs & finished formulations.

The Valthera facility is formulation manufacturing facility that we established when we forayed into the formulation business in 2016. Spread across 94,826 sq.m., it currently contains manufacturing unit for oral solids, including tablets and capsules, and oral liquids, including oral solutions and oral suspensions. We are in the process of developing a liquid and lyophilized vials injectable line, a dry powder injectable line and a sterile powder bulk lyophilization line, which will be dedicated to manufacturing of injectables, including injectable liquids, lyophilized injectables and dry powder injectables, upon its completion. In the future, we aim to develop specialty formulations. The Valthera facility has received inspections from USFDA and inspection from WHO for GMP.